DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES. (June 2017) - Leppä, S.; Joergensen, J.; de Nully Brown, P.; Fagerli, U.; Larsen, T.S.; Janes, R.; Mannisto, S.; Munksgaard, L.; Maisenhölder, M.; Vasala, K.; Meyer, P.; Jerkeman, M.; et al.